Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma
Chien-Ming Liu(China Medical University), Wen‐Lung Ma(Asia University), Li-Hsiou Chen(Taipei Tzu Chi Hospital), Tzu-Sheng Chen(Taipei Tzu Chi Hospital), Shang-Miao Chang(Taipei Tzu Chi Hospital), Kuo-Liang Chiu(Taipei Tzu Chi Hospital), S. Yang(China Medical University), Sung‐Liang Yu(National Taiwan University), Yung-Lun Ni(Taipei Tzu Chi Hospital), Yuh‐Pyng Sher(China Medical University)
Cited by 17
Related Papers
Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
|Gastroenterology|2008|253
Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
|Hepatology|2008|207
Androgen Receptor Promotes Hepatitis B Virus–Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription
|Science Translational Medicine|2010|198
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis
|Endocrine Related Cancer|2014|188